Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Delayed Quote. Delayed  - 05/25 04:37:14 pm
113.54 USD   +0.75%
04:34p JOHNSON & JOHNS : to Participate in the Goldman Sachs 37th Annual Gl..
10:39a AGS : Pelvic mesh implants caused dire complications
02:55aDJJOHNSON & JOHNS : Washington, California Sue Johnson & Johnson Over ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Johnson & Johnson : to Participate in the Goldman Sachs 37th Annual Global Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/25/2016 | 04:34pm CEST

NEW BRUNSWICK, N.J., May 25, 2016 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 37th Annual Global Healthcare Conference on Wednesday, June 8, at the Terranea in Rancho Palos Verdes, CA. Dominic Caruso, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-goldman-sachs-37th-annual-global-healthcare-conference-300274790.html

SOURCE Johnson & Johnson

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on JOHNSON & JOHNSON
04:34p JOHNSON & JOHNSON : to Participate in the Goldman Sachs 37th Annual Global Healt..
10:39a AGS : Pelvic mesh implants caused dire complications
02:55aDJJOHNSON & JOHNSON : Washington, California Sue Johnson & Johnson Over Vaginal Me..
05/24 JOHNSON & JOHNSON : Healthcare Sector Stock Business Review
05/24 JOHNSON & JOHNSON : U.S. FDA Expands Indication of INVOKAMET® (canagliflozin/met..
05/24 JOHNSON & JOHNSON : Washington, California sue over pelvic mesh implants
05/24 JOHNSON & JOHNSON : New Phase 3 Study Findings Show STELARA® Maintained Clinical..
05/23DJSamsung Targets U.S. Drug Market With Remicade Knockoff
05/23 JOHNSON & JOHNSON : Boomer Esiason Foundation Announces Collaboration with Johns..
05/23 JOHNSON & JOHNSON : Janssen's Single-Agent DARZALEX® (daratumumab) Approved by E..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials